JOHANNESBURG (Reuters) - South Africa's No.2 drug maker Adcock Ingram posted a 10 percent fall half-year earnings on Tuesday, hit by the loss of high-margin drugs and said it would continue seeking acquisitions in emerging markets. Adcock, the nation's top over-the-counter drugs maker, said diluted headline earnings per share totalled 198.4 cents in the six months to end-March, compared with 220.7 cents a year earlier. The company said sales increased 5 percent to 2.25 billion rand. ...
Read more
No comments:
Post a Comment